CVS Health Forecasts 6.1% Q4 Revenue Growth to $103.7B with $1.00 EPS
Last quarter CVS Health reported revenues of $102.9 billion, up 7.8% year-on-year, topping analysts’ revenue estimates by 4.1% alongside an EPS beat. For Q4 analysts forecast 6.1% revenue growth to $103.7 billion with adjusted earnings of $1.00 per share.
1. Last Quarter Performance
CVS Health closed the previous quarter with $102.9 billion in revenue, marking a 7.8% year-on-year increase and exceeding analysts’ revenue projections by 4.1%. The company also delivered an EPS beat, continuing its trend of outperforming consensus expectations.
2. Q4 Expectations
Analysts project Q4 revenues of $103.7 billion, representing 6.1% growth over the prior year, and forecast adjusted earnings of $1.00 per share. Estimate revisions have been minimal over the past 30 days, indicating stable market confidence ahead of the report.
3. Peer Performance Context
Within the health insurance segment, Cigna posted 10.4% revenue growth and Centene achieved 21.9%, each beating estimates by roughly 3–4%. The sector has underperformed broader markets, with average shares down 3.1% last month versus a 2.8% decline for CVS Health.